In addition, mean CAP values, an established surrogate of liver steatosis, were found to be higher in Pi*ZZ carriers than in non-carriers, and Pi*ZZ carriers had more severe steatosis than non-carriers, whereas the median body mass index as well as the frequency of obesity and diabetes were similar in both groups [101]. Here, SERPINA1 is linked to fatty liver disease.